HOME >> BIOLOGY >> NEWS
Separated before birth: Molecular signals part fetal blood and lymphatic vessels

(Philadelphia, PA) At some point in fetal development, cells from the newly emerged blood circulatory system start out on their own and form a separate parallel network of vessels known as the lymphatic system. In the January 10th issue of Science, researchers from the University of Pennsylvania School of Medicine report the discovery of the molecular signals necessary to separate the lymph vessel network from the blood vessel network.

Their findings clarify an important juncture in fetal development, shed light on the mechanisms by which molecular signals influence vascular development, pave the way for potential therapeutics, and may ultimately clear up a minor mystery among researchers that has been brewing since the mid-1990s.

"According to our studies, the SLP-76 and Syk proteins, which we previously knew to have a signaling function in white blood cell development, are absolutely critical in separating the lymphatic system from the circulatory system," said Gary Koretzky, MD, PhD, professor in Penn's Department of Pathology and Laboratory Medicine and director of the Signal Transduction Program at the Abramson Family Cancer Research Institute. "This new role is important if we are ever to learn how to influence the growth of blood or lymphatic vessels.

For example, under some clinical circumstances, it would be useful to encourage the growth of new blood vessels or, conversely, discourage new vessels from supplying blood to growing tumors."

Since the mid-1990s, researchers have been trying to determine the exact function of SLP-76 and Syk. The proteins are related signals involved in hematopoiesis the process by which stem cells transform into red and white blood cells. To better understand the function of these signals, several groups created animal models that lacked SLP-76 or Syk in order to see what happens in their absence. Researchers in Koretzky's laboratory found that most animal models lacking SLP-76 had severe abnormalities
'"/>

Contact: Greg Lester
lesterg@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
10-Jan-2003


Page: 1 2 3

Related biology news :

1. Counting foxes before the last tally-ho
2. Study finds anti-HIV protein evolved millions of years before the emergence of AIDS
3. What are babies thinking before they start talking?
4. Can exercise before diving prevent decompression sickness?
5. Genetic info of cloned pigs may help babies before birth
6. Chromosomes are nibbled before they fuse, researchers report
7. Stop to smell the flowers - But do it before theyre pollinated
8. Ethical guidelines needed before nutrigenomic groceries come to market
9. Scientists, physicians discuss latest discoveries for stopping cancer before it starts
10. Researchers show autoantibodies occur before lupus in New England Journal of Medicine
11. New research challenges advice that men should abstain from sex before fertility treatment

Post Your Comments:
(Date:10/29/2014)... who lose their hair as a consequence of chemotherapy ... improve the scalp cooling technology that prevents hair loss. ... being pioneered by global scalp cooling manufacturing company, Paxman ... biology department of the University of Huddersfield. , The ... who has a background in the pharmacology of cancer ...
(Date:10/29/2014)... research presented at the Society for Integrative Oncology ... for the first time that it is possible ... readily available nutritional supplement, AHCC. ... Smith, Pharm.D., associate professor in the Department of ... of Texas Health Science Center at Houston (UTHealth) ...
(Date:10/29/2014)... Many factors, both genetic and environmental, have been ... of schizophrenia. Some, such as a family history ... infection with Toxoplasma gondii , a parasite ... are still viewed with skepticism. , A new ... and epidemiology at the University of Pennsylvania,s School ...
Breaking Biology News(10 mins):New technology on the way to aid cancer suffers who lose their hair after chemotherapy 2HPV infections in women eradicated by AHCC, Japanese mushroom extract 2Penn vet professor investigates parasite-schizophrenia connection 2Penn vet professor investigates parasite-schizophrenia connection 3
(Date:10/27/2014)... and TORONTO , Oct. ... www.generex.com ) (OTCQB: GNBT) today announced two presentations ... triggered by its novel proprietary cancer immunotherapeutic AE37 ... breast cancer patients. The AE37 cancer vaccine is ... Express, Inc. ( www.antigenexpress.com ). The presentations are ...
(Date:10/27/2014)... Orlando, Florida (PRWEB) October 27, 2014 ... aims at reducing and eliminating several types of ... have not been achieved in over 30 years ... of Noah's Light Foundation, proves that one mom's ... was diagnosed just before Halloween trick-or-treating, and it’s ...
(Date:10/27/2014)... October 27, 2014 Investor-Edge has ... (NASDAQ: NBIX ), Insmed Inc. (NASDAQ: ... BCRX ), Dyax Corporation (NASDAQ: DYAX ), ... five companies can be accessed at: http://investor-edge.com/register ... Composite ended at 4,483.72, up 0.69%, the Dow Jones ...
(Date:10/25/2014)... 2014 ViaDerma, Inc ... devoted to bringing new products to market, is ... ViaDerma has developed an innovative, patent-pending dual carrier ... transfer of pharmaceutical active ingredients to penetrate the ... localized therapy. The transdermal delivery method also overcomes ...
Breaking Biology Technology:Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 2Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 3Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 4FDA Approves Breakthrough in Pediatric Brain Cancer - First in 30 Years 2FDA Approves Breakthrough in Pediatric Brain Cancer - First in 30 Years 3Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 2Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 3Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 4Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 5ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 2ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 3
Cached News: